Vnitr Lek 2010, 56(Suppl 1):104-108

The strategy of laboratory diagnostics and differential diagnostics of thrombocytopenia

M. Kušnierová*, P. Kessler
Oddělení hematologie a transfuziologie Nemocnice Pelhřimov, p.o., přednosta prim. MUDr. Petr Kessler

Thrombocytopenia is a pathological state characterized by decreased platelet count under the lower limit of the physiological range, i.e. 150 × 109 per liter. This disorder can be associated with clinical manifestation of the hemorrhagic diathesis. The risk of bleeding is closely associated with the depth of platelets count decrease. Spontaneous bleeding (in absence of any other coagulation disorder) usually occurs when the platelet count decreases below 20 × 109 per liter. The first step, which should be done, when a newly diagnosed thrombocytopenia occurs, is a thorough review of a blood smear. Firstly, it is necessary to exclude the pseudothrombocytopenia, caused by an abnormal in vitro aggregation of thrombocytes, or (much less frequently) by platelet satelitism. It is also necessary to evaluate the red and white cells, especially to focus on the presence of schistocytes or blasts. Thereafter it is recommended to follow a standard diagnostic algorithm, which should be available in every hematological laboratory.

Keywords: laboratory diagnostics; thrombocytopenia; pseudothrombocytopenia

Received: March 31, 2010; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kušnierová M, Kessler P. The strategy of laboratory diagnostics and differential diagnostics of thrombocytopenia. Vnitr Lek. 2010;56(Supplementum 1):104-108.
Download citation

References

  1. Kubisz P et al. Hematologia a transfuziologia. Praha: Grada Avicenum 2006.
  2. Guidelines on the Diagnosis and Management of the Thrombotic Microangiopathic Haemolytic Anaemias. Br J Haematol 2003; 120: 556-577. Go to original source... Go to PubMed...
  3. Penka M, Bulikova A et al. Neonkologická hematologie, 2. doplněné a zcela přepracované vydání, Praha: Grada Publishing 2009, 107 s.
  4. Elting LS, Rubenstein EB, Martin CG et al. Incidence, cost and outcomes of bleeding and chemoterapy dose modification among solid tumor patients with chemoterapy - induced trombocytopenia. J Clin Oncol 2001; 19: 1137-1146. Go to original source... Go to PubMed...
  5. Colman RV, Hirsch J et al. Diagnosis of the Immune thrombocytopenic purpura. Hemostasis and Thrombosis 1994; 117: 1713-1721.
  6. Shanafelt TD, Fonseca R. Thrombocytopenia. In: Oliveira GHM, Nesbit GC, Murphy JG Mayo Clinic Medical Manual, Mayo Clinic Scientific Press 2006. Go to original source...
  7. Mant MJ, Doery JC, Gauldie J et al. Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA. Scand J Haematol 1975; 15: 161-170. Go to original source... Go to PubMed...
  8. Payne BA, Pierre RV. Pseudothrombocytopenia a laboratory artefact with potentially serious consequences. Mayo Clin Proc 1984; 59: 123-125. Go to original source... Go to PubMed...
  9. Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean MP. Blood 2004; 103: 390-398. Go to original source... Go to PubMed...
  10. Hull RD, Pineo GF, Rashob GE. Hirudin versus heparin and LMWH. J Lab Clin Med 1998; 133: 171-174. Go to original source... Go to PubMed...
  11. Becker JU. Disseminated Intravascular Coagulation: Differential Diagnosis. Br J Hematol 2007: 139: 387-415.
  12. Taylor FBJ, Toh CH, Hoots WK et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Tromb Haemost 2001; 86: 1327-1330. Go to original source... Go to PubMed...
  13. Kelton J, Smith J, Warkentin T et al. Imunoglobulin G From Patients With Heparin-Induced Thrombocytopenia Binds to a Complex of Heparin and Platelet Factor 4. Blood 1994; 83: 3232-3239. Go to original source...
  14. Koch S, Harenberg J, Odel M et al. Development of a High-Pressure Liquid Chromatography Method for Diagnosis of Heparin-Induced Thrombocytopenia. Am J Clin Pathol 2002; 117: 900-904. Go to original source... Go to PubMed...
  15. Warkentin TE. Heparin-induced thrombocytopenia: diagnosis and management. Circulation 2004; 110: 454-458. Go to original source... Go to PubMed...
  16. Young NS, Calado RT, Schering P. Current concepts in the pathophysiology and treatment of aplastic anemiae. J Blood 2006; 108: 2509-2519. Go to original source... Go to PubMed...
  17. Thomas L. Clinical Laboratory Diagnostics. Value of Laboratory Testing 1998; 7: 1527.
  18. Dunbar CE, Nienhuis AW. Myelodysplastic syndromes. Blood: Principles and practice hematology. J Blood 1995; 85: 377-414.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.